the methods also incorporate simultaneous determinations of naltrexone and its major human metabolite , 6 beta-naltrexol ( beta-ol ) , in urine , serum ( or plasma ) , red blood cells ( rbc ) , and saliva .
C0229671
serum
C0032105
plasma